OACC Stock Price, Chart, Stats & News

Oaktree Acquisition Corp. III Life Sciences
Save
262.79M
Market cap
36.86x
Current P/E
–
Forward P/E
OACC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | 3.59% |
ROE | 3.80% |
D/E | 0.00x |
Interest coverage ratio | – |
OACC valuation
P/E | 36.86x |
P/S | – |
P/B | 1.34x |
P/CF | -934.88x |
P/FCF | -935.85x |
P/OCF | -934.88x |
PEG | 5.00x |
EV multiple | 288.33x |
About
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
Similar securities
Based on sector and market capitalization
Report issue











